M. Stoeber, Oligomers of the ATPase EHD2 confine caveolae to the plasma membrane through association with actin, EMBO J, vol.31, pp.2350-2364, 2012.

B. Moren, EHD2 regulates caveolar dynamics via ATP-driven targeting and oligomerization, Mol. Biol. Cell, vol.23, pp.1316-1329, 2012.

S. Torrino, EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription, J Cell Biol, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02426440

M. Li, Effects of EHD2 interference on migration of esophageal squamous cell carcinoma, Med. Oncol, vol.30, 2013.

E. Bignotti, Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy, Gynecol. Oncol, vol.103, pp.405-416, 2006.

C. Welinder, Correlation of histopathologic characteristics to protein expression and function in malignant melanoma, PLoS One, vol.12, 2017.

J. Liu, Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma, Dig. Dis. Sci, vol.61, pp.2554-2567, 2016.

X. Yang, H. Ren, L. Yao, X. Chen, and A. He, Role of EHD2 in migration and invasion of human breast cancer cells, Tumour Biol, vol.36, pp.3717-3726, 2015.

Y. Shi, Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin, J. Mol. Histol, vol.46, pp.221-231, 2015.

F. Bray, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin, vol.68, pp.394-424, 2018.

C. M. Perou, Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

W. D. Foulkes, I. E. Smith, and J. S. Reis-filho, Triple-negative breast cancer, N. Engl. J. Med, vol.363, 1938.
URL : https://hal.archives-ouvertes.fr/hal-02463255

N. Harbeck and M. Gnant, Breast cancer. Lancet, vol.389, issue.16, pp.31891-31899, 2017.

S. R. Morris and L. A. Carey, Molecular profiling in breast cancer, Rev. Endocr. Metab. Disord, vol.8, pp.185-198, 2007.

A. Aydiner, Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment, Medicine, vol.94, 2015.

G. Bianchini, J. M. Balko, I. A. Mayer, M. E. Sanders, and L. Gianni, Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease, Nat. Rev. Clin. Oncol, vol.13, pp.674-690, 2016.

L. M. Campbell, P. J. Maxwell, and D. J. Waugh, Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer, Pharmaceuticals, vol.6, pp.929-959, 2013.

J. K. Singh, B. M. Simoes, S. J. Howell, G. Farnie, and R. B. Clarke, Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells, Breast Cancer Res, vol.15, 2013.

B. Cai, Differential roles of C-terminal Eps15 homology domain proteins as vesiculators and tubulators of recycling endosomes, J. Biol. Chem, vol.288, pp.30172-30180, 2013.

C. Lamaze, N. Tardif, M. Dewulf, S. Vassilopoulos, and C. M. Blouin, The caveolae dress code: structure and signaling, Curr. Opin. Cell Biol, vol.47, pp.117-125, 2017.

I. Yeow, EHD Proteins Cooperate to Generate Caveolar Clusters and to Maintain Caveolae during Repeated Mechanical Stress, Curr. Biol, vol.27, pp.2951-2962, 2017.

K. Inoue, Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer, Cancer Res, vol.60, pp.2290-2299, 2000.

Y. Kitadai, Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice, Br. J. Cancer, vol.81, pp.647-653, 1999.

R. K. Singh and B. L. Lokeshwar, Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs, Mol. Cancer, vol.8, 2009.

H. Ha, B. Debnath, and N. Neamati, Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases, Theranostics, vol.7, pp.1543-1588, 2017.

Y. Kim, Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma, PLoS One, vol.12, 2017.

C. Lamaze and S. Torrino, Caveolae and cancer: A new mechanical perspective, Biomed. J, vol.38, pp.367-379, 2015.

B. D. Lehmann, Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J. Clin. Invest, vol.121, pp.2750-2767, 2011.

D. Amadori, Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study, Breast Cancer Res. Treat, vol.43, pp.7-14, 1997.

A. Prat, Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer, J. Clin. Oncol, vol.31, pp.203-209, 2013.

A. C. Wolff, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J. Clin. Oncol, vol.25, pp.118-145, 2007.

A. Vincent-salomon, HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?, Br. J. Cancer, vol.96, pp.654-659, 2007.

I. Bieche, Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer, Oncogene, vol.20, pp.8109-8115, 2001.

O. R. Workshop, Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E, Eur J. Cancer, vol.16, pp.1513-1515, 1979.

B. C. Langton, An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene, Cancer Res, vol.51, pp.2593-2598, 1991.

I. Bieche, Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications, Clin. Chem, vol.45, pp.1148-1156, 1999.

D. Meseure, Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value, Mol. Cancer Res, vol.14, pp.623-633, 2016.

J. A. Hanley and B. J. Mcneil, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, vol.143, pp.29-36, 1982.